- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06010576
Endoscopic Ultrasound-guided Rendezvous Versus Precut Papillotomy (ERVPP)
Endoscopic Ultrasound-guided Rendezvous Technique Versus Early Precut Papillotomy for Difficult Bile Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography: a Multicenter Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Endoscopic retrograde cholangiopancreatography (ERCP) is the preferred therapeutic modality over surgery or interventional radiology procedures in many common benign or malignant pancreatobiliary diseases in modern clinical practice, but selective bile duct cannulation may fail in up to 15% of cases.
The implication of failed endoscopic biliary access can be substantial for the following reasons: higher risk of post-ERCP pancreatitis (PEP), need for rescue procedures such as external biliary drainage by interventional radiology, risks of external biliary drainage catheter-related complications including catheter blockage.
Advanced ERCP cannulation techniques such as pancreatic guidewire-assisted biliary cannulation with or without pancreatic stenting, and precut papillotomy are recommended by guidelines in patients with difficult bile duct cannulation, but they are not without limitations. If pancreatic duct cannulation is not feasible or pancreatic guidewire-assisted biliary cannulation fails, precut papillotomy using 1 of the 3 accepted precut techniques: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome, can be performed depending on institutional expertise. Despite a higher biliary cannulation success by precut papillotomy when compared to pancreatic guidewire-assisted biliary cannulation, a higher risk of PEP has also been traditionally associated with precut papillotomy when it is performed after prolonged cannulation attempts. On the other hand, there has been growing evidence to suggest the increased risk of PEP may be related to the persistent cannulation attempts before precut rather than the precut papillotomy itself. In a recent meta-analysis of 5 randomized controlled trials comparing "early precut papillotomy" to persistent standard cannulation techniques in ERCP by attending endoscopists and advanced endoscopy trainees, the incidence of PEP was not significantly different between the "early precut papillotomy" and the persistent standard cannulation groups.
EUS-guided rendezvous technique (EUS RV) is a novel advanced interventional EUS technique that has been increasingly performed in tertiary centers for patients with failed biliary access by advanced ERCP cannulation techniques. Several variations of EUS-guided biliary drainage procedures have been described including transpapillary drainage procedures (EUS RV for biliary access, EUS-guided antegrade stenting) and transmural drainage procedures (EUS-guided choledochoduodenostomy, EUS-guided hepaticogastrostomy). EUS RV can be applied in both benign and malignant biliary conditions as a salvage technique for difficult biliary access when the major papilla is accessible. EUS RV involves the following key steps: access of the dilated bile duct by a EUS needle under EUS guidance, performance of cholangiogram, advancement of the rendezvous guidewire into the bile duct and out of the major papilla into duodenum, and exchange of echoendoscope back to a duodenoscope to complete the procedure by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire. Because EUS RV achieves biliary access by targeting the dilated bile duct with antegrade passage of guidewire from bile duct through the papillary orifice, theoretically this would carry a lower risk of procedure-related PEP when compared to early precut papillotomy.
In a recently published consensus guidelines on the optimal management in interventional EUS procedures proposed by experts from our endoscopy research group and other member institutions of the Asian EUS Group, EUS-guided biliary drainage is recommended as the procedure of choice for biliary drainage in patients with failed ERCP when expertise is available based on high level evidence. The technical success of EUS RV has increased over time to 73% to 100% in studies published after 2012.
Studies directly comparing EUS RV and precut papillotomy in patients with difficult biliary access remain scarce. In a single center retrospective study published in 2012 comparing the clinical outcomes of 58 EUS RV procedures and 144 precut papillotomy procedures in patients with failed bile duct cannulation in ERCP, Dhir V et al reported a significantly higher first session technical success of biliary access (98% vs 90%, p = 0.038) and a lower adverse event rate (3.4% vs 6.9%, p = 0.27) in the EUS RV group. In a multicenter retrospective study published in 2017 by Lee A et al comparing the clinical outcomes of 50 EUS RV + 11 EUS-guided transmural drainage procedures and 142 precut papillotomy procedures in patients with failed bile duct cannulation in ERCP, a higher technical success of biliary access (94% vs 75%) was also demonstrated in the EUS RV group.
Despite the promising results of EUS RV in patients with failed biliary cannulation by advanced ERCP techniques, there has been no dedicated randomized controlled trial directly comparing EUS RV and early precut papillotomy in patients with difficult bile duct cannulation. We aim to conduct a multicenter randomized controlled trial comparing the clinical efficacy of these 2 advanced endoscopic biliary access techniques in patients with difficult bile duct cannulation in ERCP.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Felix Sia
- Phone Number: 26370428
- Email: felixsia@cuhk.edu.hk
Study Locations
-
-
New Territories
-
Shatin, New Territories, Hong Kong
- Recruiting
- Prince of Wales Hospital, The Chinese University of Hong Kong
-
Contact:
- Felix Sia, BS
- Phone Number: (852) 26370428
- Email: felixsia@cuhk.edu.hk
-
Principal Investigator:
- Raymond S Tang, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients age 18 years or older undergoing ERCP with indication for bile duct cannulation
- Native major papilla
- Difficult bile duct cannulation, defined by the presence of 1 of the following: 1) unsuccessful bile duct cannulation within 10 cannulation attempts, 2) unsuccessful bile duct cannulation within 10 minutes spent in cannulation, or 3) 2 unintended pancreatic duct cannulation or opacification with contrast
- Written informed consent available
Exclusion Criteria:
- Unable to provide written informed consent
- Contraindications for endoscopy due to comorbidities
- Prior biliary sphincterotomy
- Surgically altered upper gastrointestinal anatomy or duodenal obstruction precluding a standard ERCP
- Uncorrectable coagulopathy (INR > 1.5) and thrombocytopenia (platelet < 50,000) by blood product transfusion
- Pregnant patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: EUS-guided rendezvous group (EUS RV group)
In the EUS RV group, a linear array echoendoscope would be used to evaluate the common bile duct and left intrahepatic duct in order to identify the optimal route for biliary access by fine needle.
Using a 19 gauge EUS needle, the dilated biliary tree will be accessed by either a transduodenal puncture to the common bile duct or a transgastric puncture to the left intrahepatic duct under direct EUS guidance.
The optimal access route will be based on patient's anatomy after EUS assessment and left to the discretion of the investigator.
Next, a guidewire would be advanced through the needle into the bile duct and out of the papillary orifice.
The echoendoscope would then be exchanged to a duodenoscope for ERCP.
The EUS rendezvous ERCP procedure will be completed by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire to obtain biliary access.
|
A linear array echoendoscope would be used to evaluate the common bile duct and left intrahepatic duct in order to identify the optimal route for biliary access by fine needle.
Using a 19 gauge EUS needle, the dilated biliary tree will be accessed by either a transduodenal puncture to the common bile duct or a transgastric puncture to the left intrahepatic duct under direct EUS guidance.
The optimal access route will be based on patient's anatomy after EUS assessment and left to the discretion of the investigator.
Next, a guidewire would be advanced through the needle into the bile duct and out of the papillary orifice.
The echoendoscope would then be exchanged to a duodenoscope for ERCP.
The EUS rendezvous ERCP procedure will be completed by retrieving the rendezvous guidewire into the duodenoscope or by cannulation alongside the rendezvous guidewire to obtain biliary access.
|
|
Active Comparator: Early precut papillotomy group (EPP group)
In the EPP group, the precut papillotomy would be performed with 1 of the following acceptable techniques per the usual practice of the study investigator and institution: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome
|
The precut papillotomy would be performed with 1 of the following acceptable techniques per the usual practice of the study investigator and institution: 1) conventional precut papillotomy by needle knife, 2) precut fistulotomy by needle knife, or 3) transpancreatic precut papillotomy by papillotome
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The first session technical success for biliary access by EUS-guided rendezvous technique and early precut papillotomy in patients with difficult biliary access during ERCP
Time Frame: Intra-procedure, during ERCP
|
Technical success by EUS RV is defined as successful EUS-guided needle access of bile duct confirmed by bile aspiration and cholangiogram, advancement of guidewire into bile duct and out of papilla, and obtaining deep biliary cannulation by retrieving the rendezvous guidewire into duodenoscope or by cannulation alongside the rendezvous guidewire.
Technical success by Early Precut Papillotomy is defined as successful bile duct access by 1 of the 3 acceptable precut techniques in achieving deep biliary cannulation, confirmed by bile aspiration and cholangiogram.
|
Intra-procedure, during ERCP
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Procedure-related serious adverse events in the EUS-guided rendezvous group and the early precut papillotomy group within 30 days of ERCP
Time Frame: From day of procedure to Day 30 after procedure
|
Procedure-related serious adverse events include perforation, bleeding, biliary sepsis, pancreatitis, bile leak, or procedure-related mortality
|
From day of procedure to Day 30 after procedure
|
|
Procedure time to achieve biliary access by the assigned study biliary access technique
Time Frame: Intra-procedure, during ERCP
|
EUS RV group: time from EUS-guided needle access of bile duct to successful biliary cannulation by ERCP.
Early Precut Papillotomy group: time from precut initiation to successful biliary cannulation.
|
Intra-procedure, during ERCP
|
|
Need for rescue biliary drainage procedures in patients with failed biliary access by the assigned study technique, including crossover to the other study biliary access technique, need for PTBD by interventional radiology
Time Frame: Intra-procedure (during ERCP) and 3 days post procedure
|
Intra-procedure: crossover to the other study biliary access technique.
Within 3 days of procedure: need for percutaneous transhepatic biliary drainage by interventional radiology
|
Intra-procedure (during ERCP) and 3 days post procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Raymond Tang, MD, Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021.720-T
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bile Duct Diseases
-
Instituto Ecuatoriano de Enfermedades DigestivasUniversity of Sao Paulo; Universitair Ziekenhuis Brussel; The Methodist Hospital... and other collaboratorsCompletedCommon Bile Duct Neoplasms | Non-Neoplastic Bile Duct DisorderUnited States, Ecuador, Belgium, Brazil
-
Inje UniversityCompletedNeoplasms | Bile Duct Obstruction | Disorder of Bile Duct StentKorea, Republic of
-
Gujranwala medical college District Headquarters...CompletedCommon Bile Duct Diseases | Common Bile Duct Calculi | Common Bile Duct Stricture | Common Bile Duct Neoplasms | Common Bile Duct DilatationPakistan
-
Istituto Clinico HumanitasRecruitingMalignant Bile Duct ObstructionItaly
-
Nantes University HospitalUnknownOcclusion of Bile Duct With an External Bile Diversion.France
-
Theresienkrankenhaus und St. Hedwig-Klinik GmbHCompletedBile Duct Obstruction, ExtrahepaticGermany
-
Medical University of WarsawNot yet recruitingHepatectomy | Bile Leak | Liver Resection | Bile Leakage | Bile Duct DisorderPoland
-
Hospital del Rio HortegaHospital Universitario Ramon y Cajal; Hospital General Universitario de AlicanteRecruitingCholedocholithiasis | Bile Duct; Obstruction, With CalculusSpain
-
Theresienkrankenhaus und St. Hedwig-Klinik GmbHUniversity Hospital HeidelbergRecruitingBile Duct Obstruction, ExtrahepaticGermany
-
Thomas Jefferson UniversityCompletedBiliary Obstruction Due to Common Bile Duct Stone | Malignant Bile Duct ObstructionUnited States
Clinical Trials on EUS-guided rendezvous
-
California Pacific Medical Center Research InstituteUniversity of California, Los Angeles; Northwestern University; University of...CompletedDisorders of Gallbladder | Disorders of Biliary TractUnited States
-
Weill Medical College of Cornell UniversityUnknownPancreatic Cancer | Cholangiocarcinoma | Bile Duct Cancer | Chronic Pancreatitis | Biliary Stricture | Biliary Obstruction | Ampullary Cancer | Stent Obstruction | Proximal Duct Stricture | Distal Duct Stricture | Biliary Sphincter Stenosis | Impacted Stones | Peri-ampullary Diverticula | Altered AnatomyUnited States, Brazil
-
H. Lee Moffitt Cancer Center and Research InstituteAmerican Cancer Society, Inc.TerminatedEvaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic TumorsPancreatic TumorsUnited States
-
Institute for Clinical and Experimental MedicineRecruitingPancreatic Neuroendocrine Tumors (pNET) | Pancreatic Cystic Neoplasms | Endoscopic Ultrasound-Guided Radiofrequency AblationCzechia
-
Samsung Medical CenterCompletedTumor Appearance of Biliary System ObstructionKorea, Republic of
-
Qilu Hospital of Shandong UniversityNot yet recruiting
-
Qilu Hospital of Shandong UniversityNot yet recruitingBleeding | Cirrhosis | Portal Hypertension
-
Palacky UniversityCompletedPancreatitis, Acute Necrotizing | Walled Off NecrosisCzechia
-
Centro Hospitalar De São João, E.P.E.UnknownPancreatic Neoplasm | Biopsy, Fine-Needle | EndosonographyPortugal
-
Chinese University of Hong KongRecruiting